메뉴 건너뛰기




Volumn 21, Issue 1, 2007, Pages 65-68

Spotlight on reteplase in thrombotic occlusive disorders

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRIN; PLASMIN; PLASMINOGEN ACTIVATOR; RETEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

EID: 33846931393     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200721010-00008     Document Type: Review
Times cited : (16)

References (42)
  • 1
    • 0029826062 scopus 로고    scopus 로고
    • Reteplase: A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction
    • Oct;
    • Noble S, McTavish D. Reteplase: a review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996 Oct; 52: 589-605
    • (1996) Drugs , vol.52 , pp. 589-605
    • Noble, S.1    McTavish, D.2
  • 2
    • 33846896097 scopus 로고    scopus 로고
    • Protein Design Labs Inc, Fremont CA, PDL Biopharma Inc, Dec
    • Protein Design Labs Inc. Retavase® (reteplase) prescribing information. Fremont (CA): PDL Biopharma Inc., 2005 Dec
    • (2005) Retavase® (reteplase) prescribing information
  • 3
    • 0032906274 scopus 로고    scopus 로고
    • Current clinical use of reteplase for thrombolysis: A pharmacokinetic-pharmacodynamic perspective
    • Apr;
    • Martin U, Kaufmann B, Neugebauer G. Current clinical use of reteplase for thrombolysis: a pharmacokinetic-pharmacodynamic perspective. Clin Pharmacokinet 1999 Apr; 36: 265-76
    • (1999) Clin Pharmacokinet , vol.36 , pp. 265-276
    • Martin, U.1    Kaufmann, B.2    Neugebauer, G.3
  • 4
    • 0026595548 scopus 로고
    • Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis
    • Martin U, Sponer G, Strein K. Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis. J Am Coll Cardiol 1992; 19: 433-40
    • (1992) J Am Coll Cardiol , vol.19 , pp. 433-440
    • Martin, U.1    Sponer, G.2    Strein, K.3
  • 5
    • 0034643938 scopus 로고    scopus 로고
    • High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis in Myocardial Infarction) 14. The TIMI 14 Platelet Substudy Investigators
    • Jun 13;
    • Coulter SA, Cannon CP, Ault KA, et al. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (Thrombolysis in Myocardial Infarction) 14. The TIMI 14 Platelet Substudy Investigators. Circulation 2000 Jun 13; 101: 2690-5
    • (2000) Circulation , vol.101 , pp. 2690-2695
    • Coulter, S.A.1    Cannon, C.P.2    Ault, K.A.3
  • 6
    • 27944489616 scopus 로고    scopus 로고
    • Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction
    • Dec;
    • Szabo S, Etzel D, Ehlers R, et al. Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction. J Thromb Thrombolysis 2005 Dec; 20 (3): 155-61
    • (2005) J Thromb Thrombolysis , vol.20 , Issue.3 , pp. 155-161
    • Szabo, S.1    Etzel, D.2    Ehlers, R.3
  • 7
    • 9144219772 scopus 로고    scopus 로고
    • Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase
    • Jan 15;
    • Merlini PA, Repetto A, Andreoli AM, et al. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase. Am J Cardiol 2004 Jan 15; 93 (2): 195-8
    • (2004) Am J Cardiol , vol.93 , Issue.2 , pp. 195-198
    • Merlini, P.A.1    Repetto, A.2    Andreoli, A.M.3
  • 8
    • 0026012337 scopus 로고
    • Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.022 in healthy volunteers
    • Martin U, von Möllendorff E, Akpan W, et al. Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.022 in healthy volunteers. Thromb Haemost 1991; 66: 569-74
    • (1991) Thromb Haemost , vol.66 , pp. 569-574
    • Martin, U.1    von Möllendorff, E.2    Akpan, W.3
  • 9
    • 0026047886 scopus 로고
    • Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers
    • Martin U, von Möllendorff E, Akpan W, et al. Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clin Pharmacol Ther 1991; 50: 429-36
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 429-436
    • Martin, U.1    von Möllendorff, E.2    Akpan, W.3
  • 11
    • 0030713356 scopus 로고    scopus 로고
    • Double- versus single-bolus thrombolysis with reteplase for acute myocardial infarction: A pharmacokinetic and pharmacodynamic study
    • May;
    • Grunewald M, Muller M, Ellbruck D, et al. Double- versus single-bolus thrombolysis with reteplase for acute myocardial infarction: a pharmacokinetic and pharmacodynamic study. Fibrinolysis Proteolysis 1997 May; 11: 137-45
    • (1997) Fibrinolysis Proteolysis , vol.11 , pp. 137-145
    • Grunewald, M.1    Muller, M.2    Ellbruck, D.3
  • 12
    • 0029560188 scopus 로고
    • Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat
    • Kuiper J, van de Bilt H, Martin U, et al. Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat. Thromb Haemost 1995; 74: 1501-10
    • (1995) Thromb Haemost , vol.74 , pp. 1501-1510
    • Kuiper, J.1    van de Bilt, H.2    Martin, U.3
  • 13
    • 0343849937 scopus 로고    scopus 로고
    • Randomized comparison of coronary thrombolysis achieved with double bolus reteplase (r-PA) and front-loaded, "accelerated" alteplase (rt-PA) in patients with acute myocardial infarction
    • Sep 1;
    • Bode C, Smalling RW, Berg G, et al. Randomized comparison of coronary thrombolysis achieved with double bolus reteplase (r-PA) and front-loaded, "accelerated" alteplase (rt-PA) in patients with acute myocardial infarction. Circulation 1996 Sep 1; 94 (5): 891-8
    • (1996) Circulation , vol.94 , Issue.5 , pp. 891-898
    • Bode, C.1    Smalling, R.W.2    Berg, G.3
  • 14
    • 0029066701 scopus 로고
    • More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction
    • Smalling RW, Bode C, Kalbfleisch J. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 1995; 91: 2725-32
    • (1995) Circulation , vol.91 , pp. 2725-2732
    • Smalling, R.W.1    Bode, C.2    Kalbfleisch, J.3
  • 15
    • 0030879325 scopus 로고    scopus 로고
    • A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    • Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators, Oct 16;
    • Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med 1997 Oct 16; 337: 1118-23
    • (1997) N Engl J Med , vol.337 , pp. 1118-1123
  • 16
    • 33846898686 scopus 로고    scopus 로고
    • Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics [published erratum appears in Lancet 1995 Oct 7; 346 (8980): 980]. Lancet 1995; 346 (8971): 329-36
    • Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics [published erratum appears in Lancet 1995 Oct 7; 346 (8980): 980]. Lancet 1995; 346 (8971): 329-36
  • 17
    • 10944239058 scopus 로고    scopus 로고
    • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)
    • Aug 31;
    • Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 Aug 31; 110 (9): e82-292
    • (2004) Circulation , vol.110 , Issue.9
    • Antman, E.M.1    Anbe, D.T.2    Armstrong, P.W.3
  • 18
    • 0037014565 scopus 로고    scopus 로고
    • Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Trial. The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Investigators
    • Jul 3;
    • Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Trial. The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Investigators. J Am Coll Cardiol 2002 Jul 3; 40: 71-7
    • (2002) J Am Coll Cardiol , vol.40 , pp. 71-77
    • Morrow, D.A.1    Antman, E.M.2    Sayah, A.3
  • 19
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
    • The GUSTO V Investigators, Jun 16;
    • The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001 Jun 16; 357: 1905-14
    • (2001) Lancet , vol.357 , pp. 1905-1914
  • 20
    • 0037032380 scopus 로고    scopus 로고
    • Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. The GUSTO V Investigators
    • Nov 6;
    • Lincoff AM, Califf RM, Van de Werf F, et al. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. The GUSTO V Investigators. JAMA 2002 Nov 6; 288: 2130-5
    • (2002) JAMA , vol.288 , pp. 2130-2135
    • Lincoff, A.M.1    Califf, R.M.2    Van de Werf, F.3
  • 21
    • 0034332695 scopus 로고    scopus 로고
    • Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial
    • Nov 1;
    • Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) trial. J Am Coll Cardiol 2000 Nov 1; 36: 1489-96
    • (2000) J Am Coll Cardiol , vol.36 , pp. 1489-1496
    • Herrmann, H.C.1    Moliterno, D.J.2    Ohman, E.M.3
  • 22
    • 0036847872 scopus 로고    scopus 로고
    • Declining-dose study of reteplase treatment for lower extremity arterial occlusions
    • Nov;
    • Castaneda F, Swischuk JL, Li RZ, et al. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. J Vasc Interv Radiol 2002 Nov; 13: 1093-8
    • (2002) J Vasc Interv Radiol , vol.13 , pp. 1093-1098
    • Castaneda, F.1    Swischuk, J.L.2    Li, R.Z.3
  • 23
    • 1542313878 scopus 로고    scopus 로고
    • Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: Results from the RELAX trial
    • Mar;
    • Ouriel K, Castaneda F, McNamara T, et al. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial. J Vasc Interv Radiol 2004 Mar; 15 (3): 229-38
    • (2004) J Vasc Interv Radiol , vol.15 , Issue.3 , pp. 229-238
    • Ouriel, K.1    Castaneda, F.2    McNamara, T.3
  • 24
    • 33744805092 scopus 로고    scopus 로고
    • Peripheral arteries: Treatment with antibodies of platelet receptors and reteplase for thrombolysis: APART trial
    • Tepe G, Hopfenzitz C, Dietz K, et al. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis: APART trial. Radiology 2006; 239 (3): 892-900
    • (2006) Radiology , vol.239 , Issue.3 , pp. 892-900
    • Tepe, G.1    Hopfenzitz, C.2    Dietz, K.3
  • 25
    • 33846917095 scopus 로고    scopus 로고
    • Intraarterial reteplase infusion for acute stroke intervention: Inital experience [abstract no. 31]
    • Barr JD, Loges R, Magdinec M. Intraarterial reteplase infusion for acute stroke intervention: inital experience [abstract no. 31]. J Vasc Interv Radiol 2000; 12 (2 Pt 2): S13
    • (2000) J Vasc Interv Radiol , vol.12 , Issue.2 PART 2
    • Barr, J.D.1    Loges, R.2    Magdinec, M.3
  • 26
    • 0034978362 scopus 로고    scopus 로고
    • Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke
    • Jul;
    • Qureshi AI, Ali Z, Suri MFK, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001 Jul; 49: 41-8
    • (2001) Neurosurgery , vol.49 , pp. 41-48
    • Qureshi, A.I.1    Ali, Z.2    Suri, M.F.K.3
  • 27
    • 0036871178 scopus 로고    scopus 로고
    • Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study
    • Nov;, discussion 1327-9
    • Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002 Nov; 51 (5): 1319-27; discussion 1327-9
    • (2002) Neurosurgery , vol.51 , Issue.5 , pp. 1319-1327
    • Qureshi, A.I.1    Siddiqui, A.M.2    Suri, M.F.3
  • 28
    • 1242316383 scopus 로고    scopus 로고
    • Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke
    • Feb;
    • Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. Am J Neuroradiol 2004 Feb; 25 (2): 322-8
    • (2004) Am J Neuroradiol , vol.25 , Issue.2 , pp. 322-328
    • Qureshi, A.I.1    Siddiqui, A.M.2    Kim, S.H.3
  • 29
    • 33846899633 scopus 로고    scopus 로고
    • A prospective study to assess the safety and efficacy of intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke
    • Feb 1;
    • Qureshi AI, Kirmani JF, Janjua N, et al. A prospective study to assess the safety and efficacy of intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke. Stroke 2006 Feb 1; 37 (2): 705
    • (2006) Stroke , vol.37 , Issue.2 , pp. 705
    • Qureshi, A.I.1    Kirmani, J.F.2    Janjua, N.3
  • 30
    • 33846926479 scopus 로고    scopus 로고
    • Reopro Retavse Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE): Interim safety and efficacy results
    • abstract no. LB1, Feb 16-18; Kissimmee FL
    • Warach S, Butman J, Davis L, et al. Reopro Retavse Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE): interim safety and efficacy results [abstract no. LB1]. International Stroke Conference; 2006 Feb 16-18; Kissimmee (FL)
    • (2006) International Stroke Conference
    • Warach, S.1    Butman, J.2    Davis, L.3
  • 31
    • 1642577004 scopus 로고    scopus 로고
    • Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer
    • Jan;
    • Liu CY, Jain V, Shields AF, et al. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer. J Vasc Interv Radiol 2004 Jan; 15 (1 Pt 1): 39-44
    • (2004) J Vasc Interv Radiol , vol.15 , Issue.1 PART 1 , pp. 39-44
    • Liu, C.Y.1    Jain, V.2    Shields, A.F.3
  • 32
    • 0036708493 scopus 로고    scopus 로고
    • Reteplase for clearance of occluded venous catheters
    • Sep 1;
    • Owens L. Reteplase for clearance of occluded venous catheters. Am J Health Syst Pharm 2002 Sep 1; 59 (17): 1638-40
    • (2002) Am J Health Syst Pharm , vol.59 , Issue.17 , pp. 1638-1640
    • Owens, L.1
  • 33
    • 0035427948 scopus 로고    scopus 로고
    • The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters
    • Aug;
    • Castner D. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters. Nephrol Nurs J 2001 Aug; 28 (4): 403-19
    • (2001) Nephrol Nurs J , vol.28 , Issue.4 , pp. 403-419
    • Castner, D.1
  • 34
    • 0347135833 scopus 로고    scopus 로고
    • Efficacy of reteplase in poorly functioning hemodialysis catheters
    • Jan;
    • Falk A, Samson W, Uribarri J, et al. Efficacy of reteplase in poorly functioning hemodialysis catheters. Clin Nephrol 2004 Jan; 61 (1): 47-53
    • (2004) Clin Nephrol , vol.61 , Issue.1 , pp. 47-53
    • Falk, A.1    Samson, W.2    Uribarri, J.3
  • 35
    • 1842579552 scopus 로고    scopus 로고
    • The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center
    • Hyman G, England M, Kibede S, et al. The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center. Nephron Clin Pract 2004; 96 (2): c39-42
    • (2004) Nephron Clin Pract , vol.96 , Issue.2
    • Hyman, G.1    England, M.2    Kibede, S.3
  • 36
    • 0242693182 scopus 로고    scopus 로고
    • Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer
    • Nov;
    • Terrill KR, Lemons RS, Goldsby RE. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer. J Pediatr Hematol Oncol 2003 Nov; 25 (11): 864-7
    • (2003) J Pediatr Hematol Oncol , vol.25 , Issue.11 , pp. 864-867
    • Terrill, K.R.1    Lemons, R.S.2    Goldsby, R.E.3
  • 37
    • 0037318513 scopus 로고    scopus 로고
    • Reteplase for dysfunctional hemodialysis catheter clearance
    • Feb;
    • Hilleman DE, Dunlay RW, Packard KA. Reteplase for dysfunctional hemodialysis catheter clearance. Pharmacotherapy 2003 Feb; 23: 137-41
    • (2003) Pharmacotherapy , vol.23 , pp. 137-141
    • Hilleman, D.E.1    Dunlay, R.W.2    Packard, K.A.3
  • 38
    • 33846929573 scopus 로고    scopus 로고
    • Pulse-spray pharmacomechanical thrombolysis (PSPMT) of clotted hemodialysis grafts with reteplase (RPA) [abstract no. 321]
    • Hilleman DE, Lanspa TJ, Lenz TL. Pulse-spray pharmacomechanical thrombolysis (PSPMT) of clotted hemodialysis grafts with reteplase (RPA) [abstract no. 321]. J Vasc Interv Radiol 2002; 13 (2 Pt 2): S109
    • (2002) J Vasc Interv Radiol , vol.13 , Issue.2 PART 2
    • Hilleman, D.E.1    Lanspa, T.J.2    Lenz, T.L.3
  • 39
    • 0000978974 scopus 로고    scopus 로고
    • Percutaneous thrombolysis of hemodialysis grafts using reteplase [abstract no. 202]
    • Gibbens D, Depalma J, Albanese J, et al. Percutaneous thrombolysis of hemodialysis grafts using reteplase [abstract no. 202]. J Vasc Interv Radiol 2000; 11 (2 Pt 2): 250
    • (2000) J Vasc Interv Radiol , vol.11 , Issue.2 PART 2 , pp. 250
    • Gibbens, D.1    Depalma, J.2    Albanese, J.3
  • 40
    • 0001698314 scopus 로고    scopus 로고
    • Initial experience with reteplase using the 'lyse and wait' technique in thrombosed dialysis grafts [abstract no. 207]
    • Flick PA, Das M, Horton K, et al. Initial experience with reteplase using the 'lyse and wait' technique in thrombosed dialysis grafts [abstract no. 207]. J Vasc Interv Radiol 2000; 11 (2 Pt 2): 252
    • (2000) J Vasc Interv Radiol , vol.11 , Issue.2 PART 2 , pp. 252
    • Flick, P.A.1    Das, M.2    Horton, K.3
  • 41
    • 0032802952 scopus 로고    scopus 로고
    • Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
    • Jul;
    • Tebbe U, Graf A, Kamke W, et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 1999 Jul; 138 (1 Pt 1): 39-44
    • (1999) Am Heart J , vol.138 , Issue.1 PART 1 , pp. 39-44
    • Tebbe, U.1    Graf, A.2    Kamke, W.3
  • 42
    • 0142104875 scopus 로고    scopus 로고
    • Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute mycocardial infarction: Dichotomous response as a function of age in the GUSTO V trial
    • Oct;
    • Savonitto S, Armstrong PW, Lincoff AM, et al. Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute mycocardial infarction: dichotomous response as a function of age in the GUSTO V trial. Eur Heart J 2003 Oct; 24 (20): 1807-14
    • (2003) Eur Heart J , vol.24 , Issue.20 , pp. 1807-1814
    • Savonitto, S.1    Armstrong, P.W.2    Lincoff, A.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.